Biovail Corporation Appoints Dr. Peter Silverstone Senior Vice-President

TORONTO--(BUSINESS WIRE)--May 9, 2006--Biovail Corporation (NYSE:BVF - News; TSX:BVF - News) today announced that it has named Dr. Peter Silverstone Senior Vice-President, Medical and Scientific Affairs. Dr. Silverstone will focus on the rapid clinical development and the effective registration of Biovail’s pipeline products.

MORE ON THIS TOPIC